Back

GRaNIE and GRaNPA: Inference and evaluation of enhancer-mediated gene regulatory networks applied to study macrophages

Kamal, A.; Arnold, C.; Claringbould, A.; Moussa, R.; Daga, N.; Nogina, D.; Kholmatov, M.; Servaas, N.; Mueller-Dott, S.; Reyes-Palomares, A.; Palla, G.; Sigalova, O.; Bunina, D.; Pabst, C.; Zaugg, J. B.

2022-02-07 genomics
10.1101/2021.12.18.473290 bioRxiv
Show abstract

Among the biggest challenges in the post-GWAS (genome-wide association studies) era is the interpretation of disease-associated genetic variants in non-coding genomic regions. Enhancers have emerged as key players in mediating the effect of genetic variants on complex traits and diseases. Their activity is regulated by a combination of transcription factors (TFs), epigenetic changes and genetic variants. Several approaches exist to link enhancers to their target genes, and others that infer TF-gene connections. However, we currently lack a framework that systematically integrates enhancers into TF-gene regulatory networks. Furthermore, we lack an unbiased way of assessing whether inferred regulatory interactions are biologically meaningful. Here we present two methods, implemented as user-friendly R packages: GRaNIE (Gene Regulatory Network Inference including Enhancers) for building enhancer-based gene regulatory networks (eGRNs) and GRaNPA (Gene Regulatory Network Performance Analysis) for evaluating GRNs. GRaNIE jointly infers TF-enhancer, enhancer-gene and TF-gene interactions by integrating open chromatin data such as ATAC-Seq or H3K27ac with RNA-seq across a set of samples (e.g. individuals), and optionally also Hi-C data. GRaNPA is a general framework for evaluating the biological relevance of TF-gene GRNs by assessing their performance for predicting cell-type specific differential expression. We demonstrate the power of our tool-suite by investigating gene regulatory mechanisms in macrophages that underlie their response to infection and cancer, their involvement in common genetic diseases including autoimmune diseases, and identify the TF PURA as putative regulator of pro-inflammatory macrophage polarisation. Availability- GRaNIE: https://bioconductor.org/packages/release/bioc/html/GRaNIE.html - GRaNPA: https://git.embl.de/grp-zaugg/GRaNPA Graphical abstract O_FIG_DISPLAY_L [Figure 1] M_FIG_DISPLAY C_FIG_DISPLAY

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Bioinformatics
1061 papers in training set
Top 1%
22.4%
2
NAR Genomics and Bioinformatics
214 papers in training set
Top 0.1%
17.4%
3
Computational and Structural Biotechnology Journal
216 papers in training set
Top 0.3%
8.4%
4
Frontiers in Genetics
197 papers in training set
Top 0.8%
6.3%
50% of probability mass above
5
BMC Bioinformatics
383 papers in training set
Top 2%
4.3%
6
Frontiers in Immunology
586 papers in training set
Top 2%
3.6%
7
Nucleic Acids Research
1128 papers in training set
Top 6%
3.6%
8
PLOS Computational Biology
1633 papers in training set
Top 10%
3.6%
9
Briefings in Bioinformatics
326 papers in training set
Top 2%
3.1%
10
Bioinformatics Advances
184 papers in training set
Top 2%
2.4%
11
Scientific Reports
3102 papers in training set
Top 51%
2.1%
12
GigaScience
172 papers in training set
Top 1%
1.9%
13
Genome Biology
555 papers in training set
Top 4%
1.8%
14
Genome Research
409 papers in training set
Top 3%
1.3%
15
PLOS ONE
4510 papers in training set
Top 59%
1.3%
16
PLOS Genetics
756 papers in training set
Top 12%
0.9%
17
Patterns
70 papers in training set
Top 2%
0.9%
18
G3 Genes|Genomes|Genetics
351 papers in training set
Top 2%
0.9%
19
Epigenetics & Chromatin
42 papers in training set
Top 0.2%
0.9%
20
BMC Genomics
328 papers in training set
Top 5%
0.8%
21
Genetic Epidemiology
46 papers in training set
Top 0.8%
0.7%
22
Genomics
60 papers in training set
Top 3%
0.7%
23
F1000Research
79 papers in training set
Top 6%
0.6%
24
BMC Medical Genomics
36 papers in training set
Top 2%
0.6%